| (CNY) | Dec 2017 | Y/Y change |
|---|---|---|
| Revenue | 2.81B | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 600664.SS returned +102.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +136.8% |
| 1 year | +102.2% |
| 5 years | +164.3% |
| 10 years | +9.7% |
| All-time high | ¥15.06 (Oct 2010) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ¥1,000 in 600664.SS would be worth today ›No. Harbin Pharmaceutical Group Co., Ltd. has not paid a dividend in the past 12 months.
Harbin Pharmaceutical Group Co., Ltd. is part of the Healthcare sector.
Harbin Pharmaceutical Group Co., Ltd. has a market cap of 20.70B CNY, based on the latest quote.
